Publisher
Springer Science and Business Media LLC
Reference100 articles.
1. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Explorer database: incidence - SEER research data, kidney and renal pelvis cancer SEER incidence rates by age at diagnosis, Sub (2013-2017), National Cancer Institute, DCCPS, Surveillance Research Program. https://seer.cancer.gov/explorer/application.html?site = 72&data_type = 1&graph_type = 3&compareBy = sex&chk_sex_1 = 1&chk_sex_3 = 3&chk_sex_2 = 2&race = 1&rate_type = 1&advopt_precision = 1&advopt_display = 2. Accessed 7 Aug 2020
2. Dome JS, Fernandez CV, Mullen EA, Kalapurakal JA, Geller JI, Huff V, et al. Children’s Oncology Group’s 2013 blueprint for research: renal tumors. Pediatr Blood Cancer. 2013;60:994–1000.
3. D’Angio GJ. The National Wilms tumor study: a 40 year perspective. Lifetime Data Anal. 2007;13:463–70.
4. Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43:705–15.
5. Chagtai T, Zill C, Dainese L, Wegert J, Savola S, Popov S, et al. Gain of 1q as a prognostic biomarker in Wilms tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial: a SIOP renal tumours biology consortium study. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34:3195–203.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献